These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 10052898

  • 1. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
    Maesaki S, Marichal P, Hossain MA, Sanglard D, Vanden Bossche H, Kohno S.
    J Antimicrob Chemother; 1998 Dec; 42(6):747-53. PubMed ID: 10052898
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [Abstract] [Full Text] [Related]

  • 3. Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains.
    Maesaki S, Marichal P, Vanden Bossche H, Sanglard D, Kohno S.
    J Antimicrob Chemother; 1999 Jul; 44(1):27-31. PubMed ID: 10459807
    [Abstract] [Full Text] [Related]

  • 4. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 5. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ, Kasai M, Francesconi A, Landsman D, Chanock SJ.
    J Med Vet Mycol; 1997 Jan; 35(2):133-7. PubMed ID: 9147273
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S, Khosravi AR, Mousavi SA, Nikbakht-Brojeni GH.
    J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
    [Abstract] [Full Text] [Related]

  • 7. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
    Sanglard D, Ischer F, Monod M, Bille J.
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
    [Abstract] [Full Text] [Related]

  • 8. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD, Midgley J, Gazzard BG.
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [Abstract] [Full Text] [Related]

  • 9. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D.
    Med Mycol; 1998 Dec; 36 Suppl 1():119-28. PubMed ID: 9988500
    [Abstract] [Full Text] [Related]

  • 10. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
    Henry KW, Cruz MC, Katiyar SK, Edlind TD.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1968-74. PubMed ID: 10428921
    [Abstract] [Full Text] [Related]

  • 11. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S, Rahkhoodaee F, Raymond M.
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
    [Abstract] [Full Text] [Related]

  • 12. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
    Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
    [Abstract] [Full Text] [Related]

  • 13. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E, Costa-de-Oliveira S, Dias AS, Guerra J, Rodrigues AG, Pina-Vaz C.
    FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
    [Abstract] [Full Text] [Related]

  • 14. Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
    Jain P, Akula I, Edlind T.
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3195-201. PubMed ID: 14506030
    [Abstract] [Full Text] [Related]

  • 15. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
    White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW.
    Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
    [Abstract] [Full Text] [Related]

  • 16. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
    Denardi LB, Mario DA, Loreto ÉS, Santurio JM, Alves SH.
    Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097
    [Abstract] [Full Text] [Related]

  • 17. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Sanglard D, Ischer F, Koymans L, Bille J.
    Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
    [Abstract] [Full Text] [Related]

  • 18. Azole resistance in Candida albicans from animals: Highlights on efflux pump activity and gene overexpression.
    Rocha MFG, Bandeira SP, de Alencar LP, Melo LM, Sales JA, Paiva MAN, Teixeira CEC, Castelo-Branco DSCM, Pereira-Neto WA, Cordeiro RA, Sidrim JJC, Brilhante RSN.
    Mycoses; 2017 Jul; 60(7):462-468. PubMed ID: 28295690
    [Abstract] [Full Text] [Related]

  • 19. Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients.
    Stringaro A, Molinari A, Calcabrini A, Arancia G, Ceddia PG, Cianfriglia M, Poloni F, Mondello F, Angiolella L, De Bernardis F, Cassone A.
    Microb Drug Resist; 2002 Jul; 8(3):235-44. PubMed ID: 12363014
    [Abstract] [Full Text] [Related]

  • 20. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
    Smith WL, Edlind TD.
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.